At Viridian, we are committed to developing and delivering better medicines for people while conducting our business with integrity, accountability, and respect. We measure success not only by what we achieve, but by how we achieve it: through ethical decision making and responsible business practices grounded in our values.

Our Compliance & Ethics Program (the “Program”) advances this commitment by helping us prevent, identify, and address issues—and by supporting ethical decision making across the organization. The Program is purposely designed to integrate industry’s best practices and governmental guidance to promote accountability and proactive risk management. Our Board of Directors and senior leaders, including the Chief Compliance Officer, oversee the Program to ensure it is properly resourced and scalable as Viridian grows and our risk profile evolves. We routinely assess and strengthen the Program so our teams have the support they need amid changing operations and external risks.

Compliance at Viridian is a shared responsibility. Every employee and partner is expected to follow our Code of Business Conduct and Ethics, raise questions or concerns, and act in ways that protect our patients, our colleagues, and our reputation. Through strong governance, transparency, and continuous improvement, we build a culture of compliance that enables responsible growth and long term success.

• Code of Business Conduct and Ethics
• California Declaration of Comprehensive Compliance Program